NCT00724919已完成不适用
Association of Antibiotic Utilization Measures and Control of Extended-Spectrum β-Lactamases (ESBLs) (A Post-Intervention Surveillance Study)
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 256 人开始时间: 2003年12月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 256
- 主要终点
- The acquisition rate of ESBL producing E. coli or K. pneumoniae at the end of surveillance phase
研究概览
简要总结
To determine the acquisition rate of ESBL producing E. coli or K. pneumoniae, post- intervention in the selected medical centres
详细描述
This is post-interventional study to follow the acquisition rate of ESBP producing E. coli or K. pneumoniae at the sites involved in a previous interventional study.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
The acquisition rate of ESBL producing E. coli or K. pneumoniae at the end of surveillance phase
时间窗: 48hours
次要结局
- The infection rate due to ESBL producing E. coli, or due to K. pneumoniae at the end of surveillance phase(48hours)
研究者
相似试验
已完成
4 期
Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)Bacterial InfectionNCT00254696Wyeth is now a wholly owned subsidiary of Pfizer710
已完成
4 期
Tazocin Intervention StudyBacterial InfectionsNCT00478855Wyeth is now a wholly owned subsidiary of Pfizer500
已完成
4 期
Study Evaluation Tazocin InterventionBacterial InfectionsNCT00488189Wyeth is now a wholly owned subsidiary of Pfizer134
尚未招募
不适用
Exposure to Antibiotics and Incidence of Bacteraemia Caused by Resistant BacteriaBacteremiaNCT04065750Assistance Publique - Hôpitaux de Paris45,000
已完成
不适用
Antibiotic PRophylAxis Based on infeCTIve Risk in Cardiac Implantable Electronic DeviceDevice Related InfectionNCT04736979University Hospital of Ferrara1,044